{"id":"antiplatelet-therapy","safety":{"commonSideEffects":[{"rate":"1-5","effect":"Bleeding"},{"rate":"1-3","effect":"Gastrointestinal bleeding"},{"rate":"5-15","effect":"Dyspepsia"},{"rate":"0.5-1","effect":"Intracranial hemorrhage"}]},"_chembl":{"chemblId":"CHEMBL4298181","moleculeType":"Gene"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Antiplatelet agents work by interfering with platelet activation and adhesion through various mechanisms, such as inhibiting cyclooxygenase (aspirin), blocking ADP receptors (clopidogrel, ticagrelor), or inhibiting phosphodiesterase. This prevents platelets from clumping together and forming pathological thrombi that can occlude blood vessels and cause myocardial infarction or stroke.","oneSentence":"Antiplatelet therapy inhibits platelet aggregation to prevent blood clot formation and reduce thrombotic events.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:27:27.730Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome"},{"name":"Secondary prevention of myocardial infarction"},{"name":"Stroke prevention"},{"name":"Peripheral arterial disease"}]},"trialDetails":[{"nctId":"NCT05754957","phase":"PHASE3","title":"A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-04-07","conditions":"Acute Coronary Syndrome","enrollment":14194},{"nctId":"NCT05907694","phase":"NA","title":"Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure","status":"RECRUITING","sponsor":"Josep Rodes-Cabau","startDate":"2024-06-18","conditions":"Patent Foramen Ovale, Cryptogenic Stroke, Older Patients","enrollment":714},{"nctId":"NCT03568890","phase":"PHASE4","title":"Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2018-09-01","conditions":"Left Atrial Appendage Closure, Thrombosis, Stroke","enrollment":510},{"nctId":"NCT07496281","phase":"PHASE4","title":"OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2027-03-01","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent","enrollment":2},{"nctId":"NCT07493603","phase":"PHASE1, PHASE2","title":"A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease","status":"RECRUITING","sponsor":"Xia Liang","startDate":"2026-01-16","conditions":"Coronary Heart Disease, Coronary Artery Disease, Atheroscleroses","enrollment":30},{"nctId":"NCT07380490","phase":"NA","title":"Comparing Two PFO Closure Devices in Adults With Previous Stroke or TIA","status":"NOT_YET_RECRUITING","sponsor":"Giuseppe Tarantini","startDate":"2026-04","conditions":"Patent Foramen Ovale, Stroke, Transient Ischemic Attack (TIA)","enrollment":1260},{"nctId":"NCT05387954","phase":"PHASE3","title":"PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-07-07","conditions":"Cryptogenic Ischemic Stroke, Patent Foramen Ovale","enrollment":792},{"nctId":"NCT04475510","phase":"NA","title":"Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke","status":"RECRUITING","sponsor":"Josep Rodes-Cabau","startDate":"2020-07-08","conditions":"Patent Foramen Ovale, Ischemic Stroke, Bleeding Ulcer","enrollment":100},{"nctId":"NCT07486570","phase":"NA","title":"Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery","status":"RECRUITING","sponsor":"Medisch Spectrum Twente","startDate":"2026-02-01","conditions":"Mesenteric Vascular Disease, Colorectal Surgery, Preventive Intervention","enrollment":360},{"nctId":"NCT02928497","phase":"NA","title":"Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2017-02-06","conditions":"Stroke","enrollment":481},{"nctId":"NCT07479056","phase":"NA","title":"Randomized Active-Controlled Trial Evaluating Fexuprazan (Fexuclue Tab) for Prevention Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy After Coronary Intervention","status":"RECRUITING","sponsor":"SUK MIN SEO","startDate":"2024-10-24","conditions":"Diseases of the Circulatory System, Angina Pectoris, Unspecified","enrollment":400},{"nctId":"NCT07480629","phase":"","title":"The 10-Year Extended Follow-up of the DACAB Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Ruijin Hospital","startDate":"2026-03-15","conditions":"Coronary Artery Disease, CABG, Antiplatelet Therapy of Coronary Artery Bypass","enrollment":500},{"nctId":"NCT06179017","phase":"NA","title":"Endovascular Treatment for Mild Stroke With Acute Anterior Circulation Large Vessel Occlusion","status":"RECRUITING","sponsor":"Zhangzhou Municipal Hospital","startDate":"2024-02-07","conditions":"Mild Stroke, Acute Ischemic Stroke, Endovascular Treatment","enrollment":300},{"nctId":"NCT07478328","phase":"PHASE2","title":"Chaigui Longmu Ejiao Paste for Ischemic Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Longhua Hospital","startDate":"2026-03-08","conditions":"Ischemic Heart Disease","enrollment":60},{"nctId":"NCT07476898","phase":"PHASE3","title":"Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window","status":"NOT_YET_RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2026-03-01","conditions":"Stroke","enrollment":864},{"nctId":"NCT07475949","phase":"PHASE3","title":"Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":352},{"nctId":"NCT07475936","phase":"","title":"Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":392},{"nctId":"NCT05702034","phase":"PHASE3","title":"A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2023-02-15","conditions":"Ischemic Stroke; Ischemic Attack, Transient","enrollment":15000},{"nctId":"NCT07471867","phase":"PHASE4","title":"Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2026-03-17","conditions":"Chronic Coronary Syndrome","enrollment":100},{"nctId":"NCT07468448","phase":"PHASE3","title":"Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS)","status":"NOT_YET_RECRUITING","sponsor":"Population Health Research Institute","startDate":"2026-05-30","conditions":"Ischemic Stroke, Intracranial Atherosclerosis","enrollment":1172},{"nctId":"NCT07467213","phase":"PHASE4","title":"Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction","status":"NOT_YET_RECRUITING","sponsor":"Samsung Medical Center","startDate":"2026-04-01","conditions":"Acute Myocardial Infarction (AMI), Gastrointestinal Bleeding","enrollment":5000},{"nctId":"NCT07257198","phase":"PHASE3","title":"Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone","status":"RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2026-03-03","conditions":"NSTEMI - Non-ST Segment Elevation MI, STEMI (ST Elevation MI), Myocardial Infarction","enrollment":2570},{"nctId":"NCT07007143","phase":"PHASE4","title":"STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2025-07-31","conditions":"Mitral Regurgitation","enrollment":1032},{"nctId":"NCT05681702","phase":"PHASE4","title":"Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI","status":"RECRUITING","sponsor":"University of Florida","startDate":"2023-02-15","conditions":"Coronary Artery Disease","enrollment":90},{"nctId":"NCT07454707","phase":"PHASE3","title":"Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Stroke, Ischemic","enrollment":1204},{"nctId":"NCT06916520","phase":"PHASE4","title":"Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)","status":"RECRUITING","sponsor":"J.P.S Henriques","startDate":"2025-11-13","conditions":"Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)","enrollment":300},{"nctId":"NCT07445581","phase":"NA","title":"Tanhuo Decoction for Acute Coronary Syndrome With Cerebral Atherosclerosis in Elderly Patients","status":"NOT_YET_RECRUITING","sponsor":"Jinggang Xia, MD","startDate":"2026-02-28","conditions":"Acute Coronary Syndrome Comorbid With Cerebral Atherosclerosis","enrollment":480},{"nctId":"NCT06037889","phase":"PHASE3","title":"Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2023-11-09","conditions":"Branch Atheromatous Disease","enrollment":516},{"nctId":"NCT04667078","phase":"PHASE3","title":"REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts","status":"RECRUITING","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2022-03-02","conditions":"Acute Ischemia","enrollment":368},{"nctId":"NCT06700018","phase":"","title":"Flow Patterns and Stent Thrombosis","status":"RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-04-01","conditions":"Stent Thrombosis","enrollment":120},{"nctId":"NCT03950076","phase":"PHASE4","title":"EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-09-20","conditions":"Intracranial Hemorrhages, Atrial Fibrillation","enrollment":948},{"nctId":"NCT07432516","phase":"NA","title":"Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2026-02","conditions":"Coronary Artery Disease","enrollment":4400},{"nctId":"NCT06588595","phase":"PHASE4","title":"The Switching Antiplatelet-9 (SWAP-9) Study","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-11-01","conditions":"Coronary Arterial Disease (CAD)","enrollment":90},{"nctId":"NCT07431762","phase":"PHASE4","title":"Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Heart Valve Replacement","status":"NOT_YET_RECRUITING","sponsor":"Asan Medical Center","startDate":"2026-02-01","conditions":"Valve Replacement Surgery","enrollment":1058},{"nctId":"NCT06543082","phase":"PHASE4","title":"MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study","status":"RECRUITING","sponsor":"CHA University","startDate":"2024-08-05","conditions":"Acute Coronary Syndrome","enrollment":490},{"nctId":"NCT05225961","phase":"PHASE4","title":"ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-05-01","conditions":"Acute Ischemic Stroke","enrollment":240},{"nctId":"NCT05825573","phase":"PHASE3","title":"Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2023-05-15","conditions":"Intracardiac Thrombus, STEMI, Heart Failure","enrollment":340},{"nctId":"NCT05684055","phase":"NA","title":"\"Community-based, eHealth Supported Management of Cardiovascular Risk Factors by Lay Village Health Workers (ComBaCaL aHT TwiC 1 & ComBaCaL aHT TwiC 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2023-09-09","conditions":"Arterial Hypertension","enrollment":1354},{"nctId":"NCT05707442","phase":"PHASE3","title":"Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-02-16","conditions":"Idiopathic Intracranial Hypotension, Venous Sinus Stenosis","enrollment":74},{"nctId":"NCT05193019","phase":"","title":"Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación EPIC","startDate":"2022-03-14","conditions":"Ischemic Heart Disease, Acute Coronary Syndrome","enrollment":717},{"nctId":"NCT07243704","phase":"PHASE3","title":"Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Christian Medical College and Hospital, Ludhiana, India","startDate":"2026-02-15","conditions":"Intracerebral Haemorrhage","enrollment":5676},{"nctId":"NCT04014803","phase":"PHASE4","title":"Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2020-01-13","conditions":"Coronary Artery Disease","enrollment":3500},{"nctId":"NCT07398001","phase":"NA","title":"Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment","status":"NOT_YET_RECRUITING","sponsor":"Ulsan University Hospital","startDate":"2026-02-12","conditions":"Percutaneous Coronary Intervention, Antiplatelet Therapy, Drug-coated Balloon","enrollment":1042},{"nctId":"NCT06691191","phase":"PHASE4","title":"Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-01-08","conditions":"Coronary Artery Disease","enrollment":48},{"nctId":"NCT07384702","phase":"PHASE2","title":"Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia","status":"NOT_YET_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2026-06","conditions":"Bacteremia Due to Staphylococcus Aureus","enrollment":230},{"nctId":"NCT06228456","phase":"PHASE4","title":"Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-04-01","conditions":"Coronary Artery Disease","enrollment":50},{"nctId":"NCT07391358","phase":"NA","title":"DAPT Strategy in HBR Patients Undergoing Complex PCI Following ACS: Second-Phase Beta Testing of a Patients Decision Aid","status":"NOT_YET_RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2026-02-01","conditions":"Acute Coronary Syndrome","enrollment":26},{"nctId":"NCT03863548","phase":"","title":"French Observational Study of Complications Associated With Anticoagulants and Antiplatelet Treatment in Retina/Vitreous Surgery","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2019-01-08","conditions":"Patients Undergoing Retina/Vitreous Surgery","enrollment":748},{"nctId":"NCT07379190","phase":"PHASE3","title":"HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)","status":"NOT_YET_RECRUITING","sponsor":"Weifang Medical University","startDate":"2026-02-01","conditions":"Stroke, Acute, Stroke, Ischemic, Cerebral Infarction","enrollment":458},{"nctId":"NCT07111559","phase":"PHASE4","title":"Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial","status":"RECRUITING","sponsor":"Nippon Medical School","startDate":"2025-08-01","conditions":"Lacunar Stroke, Stroke, Ischemic Stroke","enrollment":500},{"nctId":"NCT05785897","phase":"NA","title":"STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT","status":"RECRUITING","sponsor":"IGLESIAS Juan Fernando","startDate":"2025-11-01","conditions":"ST Elevation Myocardial Infarction","enrollment":350},{"nctId":"NCT04894877","phase":"","title":"ISCHEMIA-EXTEND (Extended Follow-up)","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2012-07","conditions":"Cardiovascular Diseases, Coronary Disease, Coronary Artery Disease","enrollment":5391},{"nctId":"NCT07374718","phase":"NA","title":"Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2026-03-01","conditions":"Acute Coronary Syndrome (ACS), High Bleeding Risk(HBR), Coronary Artery Disease (CAD)","enrollment":468},{"nctId":"NCT05832762","phase":"NA","title":"Evaluation of Acute Endovascular Treatment in Symptomatic Isolated Cervical Internal Carotid Artery Occlusion (ETICA)","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2024-08-19","conditions":"Acute Ischemic Stroke","enrollment":200},{"nctId":"NCT04654052","phase":"PHASE4","title":"VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación EPIC","startDate":"2021-07-02","conditions":"Acute Coronary Syndrome, Acute Myocardial Infarction, Coronary Artery Disease","enrollment":634},{"nctId":"NCT06535568","phase":"NA","title":"Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)","status":"RECRUITING","sponsor":"Fondazione Ricerca e Innovazione Cardiovascolare ETS","startDate":"2026-01-10","conditions":"Coronary Disease, Heart Diseases, Cardiovascular Diseases","enrollment":576},{"nctId":"NCT07225842","phase":"PHASE4","title":"The Bridging Antiplatelet Therapy With Cangrelor 2 Study","status":"NOT_YET_RECRUITING","sponsor":"University of Florida","startDate":"2026-02-25","conditions":"Coronary Arterial Disease (CAD)","enrollment":50},{"nctId":"NCT06316570","phase":"PHASE3","title":"Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-04-03","conditions":"Ischemic Stroke, Acute","enrollment":1382},{"nctId":"NCT07358416","phase":"","title":"Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Petrovsky National Research Centre of Surgery","startDate":"2025-05-01","conditions":"Thrombosis, Bleeding, Cerebral Hypoxia During and/or Resulting From A Procedure","enrollment":500},{"nctId":"NCT07002476","phase":"PHASE3","title":"Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion","status":"RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2025-06-19","conditions":"Stroke","enrollment":652},{"nctId":"NCT07349979","phase":"NA","title":"PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-30","conditions":"Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease","enrollment":654},{"nctId":"NCT06853535","phase":"PHASE3","title":"Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE","status":"RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2025-05-23","conditions":"Acute Ischemic Stroke, Clopidogrel Resistance","enrollment":5138},{"nctId":"NCT07354828","phase":"","title":"Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2025-12-30","conditions":"Acute Coronary Syndrome (ACS), High Bleeding Risk (HBR), Coronary Artery Disease (CAD)","enrollment":3500},{"nctId":"NCT07329751","phase":"NA","title":"Based on the Spatio-temporal Coding Characteristics of Frontotemporal Network, This Paper Explores the Mechanism of Five-tone Speech Training in Reshaping Language Fluency Function.","status":"NOT_YET_RECRUITING","sponsor":"Fujian University of Traditional Chinese Medicine","startDate":"2025-12-31","conditions":"Aphasia","enrollment":120},{"nctId":"NCT04708587","phase":"NA","title":"Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2021-03-23","conditions":"Chronic Kidney Diseases","enrollment":900},{"nctId":"NCT04045665","phase":"PHASE3","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-12-13","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":3200},{"nctId":"NCT07349875","phase":"PHASE4","title":"Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-01","conditions":"Coronary Artery Disease (CAD)","enrollment":3826},{"nctId":"NCT05577988","phase":"PHASE3","title":"Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-06-18","conditions":"MYOCARDIAL INFARCTION","enrollment":2468},{"nctId":"NCT07347626","phase":"PHASE3","title":"Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis","status":"NOT_YET_RECRUITING","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2026-03-01","conditions":"Acute Ischemic Stroke","enrollment":786},{"nctId":"NCT06143709","phase":"","title":"Precision PCI Registry","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2020-07-17","conditions":"Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":1643},{"nctId":"NCT07337655","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Aspirin and Lansoprazole for Prevention of Preterm Birth in High-Risk Pregnant Women: A Biomarker-Enriched Trial","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2026-10-01","conditions":"Pre-term Birth","enrollment":670},{"nctId":"NCT07335107","phase":"PHASE3","title":"Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-01-12","conditions":"Acute Ischemic Stroke","enrollment":564},{"nctId":"NCT07322835","phase":"","title":"Efficacy and Safety of Reperfusion Therapy for Minor Ischemic Stroke in China","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2026-01-01","conditions":"Minor Ischemic Stroke","enrollment":5400},{"nctId":"NCT05493657","phase":"NA","title":"Aspirin vs Clopidogrel After TAVR","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2023-02-02","conditions":"Severe Aortic Stenosis","enrollment":254},{"nctId":"NCT07076082","phase":"PHASE4","title":"Vascular Trial Associated Registry Pilot","status":"RECRUITING","sponsor":"Corewell Health West","startDate":"2025-10-15","conditions":"Peripheral Arterial Disease","enrollment":350},{"nctId":"NCT07195149","phase":"PHASE3","title":"Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)","status":"RECRUITING","sponsor":"Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.","startDate":"2025-11-25","conditions":"Chronic Coronary Syndrome, Stable Coronary Artery Disease CAD","enrollment":1703},{"nctId":"NCT05050864","phase":"NA","title":"Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.","status":"RECRUITING","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2022-03-02","conditions":"Pseudotumor Cerebri, Cerebrospinal Fluid, Transverse Sinuses","enrollment":276},{"nctId":"NCT03783351","phase":"NA","title":"Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2019-05-27","conditions":"Angina, Stable, Acute Coronary Syndrome, Drug-Eluting Stents","enrollment":4009},{"nctId":"NCT07313137","phase":"","title":"Antiplatelet Use in Dementia Subtypes","status":"COMPLETED","sponsor":"Gulhane Training and Research Hospital","startDate":"2016-12","conditions":"Dementia, Dementia Disorder","enrollment":683},{"nctId":"NCT05845489","phase":"PHASE4","title":"Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2023-03-22","conditions":"Coronary Artery Disease","enrollment":11086},{"nctId":"NCT05831085","phase":"NA","title":"Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease","status":"RECRUITING","sponsor":"Duk-Woo Park, MD","startDate":"2024-06-14","conditions":"Coronary Artery Stenosis","enrollment":1500},{"nctId":"NCT07309718","phase":"","title":"MPR for Stroke Risk Assessment of ICAS","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-01","conditions":"ICAS - Intracranial Atherosclerosis, Stroke Ischemic, Hemodynamic","enrollment":400},{"nctId":"NCT04416581","phase":"PHASE4","title":"Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy","status":"RECRUITING","sponsor":"Duk-Woo Park, MD","startDate":"2021-05-12","conditions":"Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome","enrollment":3320},{"nctId":"NCT07309705","phase":"","title":"Digital Angiography-Derived Fractional Flow Assessment for Intracranial Stenosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-01","conditions":"Intracranial Atherosclerosis ICAS, Hemodynamic, Stroke","enrollment":400},{"nctId":"NCT03780062","phase":"PHASE3","title":"Interest of S100B Protein for Patient Victim of Minor Traumatic Brain Injury and Treated by Antiplatelet","status":"COMPLETED","sponsor":"Poitiers University Hospital","startDate":"2019-01-25","conditions":"Minor Traumatic Brain Injury, Treatment by Antiplatelet","enrollment":720},{"nctId":"NCT06388148","phase":"NA","title":"Endovascular Treatment for eXtra-Large Ischemic Stroke","status":"RECRUITING","sponsor":"Zhongming Qiu","startDate":"2024-06-16","conditions":"Stroke, Acute Ischemic","enrollment":286},{"nctId":"NCT05604638","phase":"PHASE3","title":"Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Guangxi Medical University","startDate":"2024-04-24","conditions":"Acute Ischemic Stroke","enrollment":348},{"nctId":"NCT07299994","phase":"","title":"Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease","status":"NOT_YET_RECRUITING","sponsor":"Sigmund Freud PrivatUniversitat","startDate":"2026-01-01","conditions":"Stroke, Thrombolysis, DAPT(Dual Antiplatelet Therapy)","enrollment":462},{"nctId":"NCT07290751","phase":"PHASE4","title":"Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-11-11","conditions":"Acute Ischemic Stroke","enrollment":976},{"nctId":"NCT07286110","phase":"PHASE1","title":"Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-12-30","conditions":"Moyamoya Disease, Moyamoya Syndrome","enrollment":66},{"nctId":"NCT07115940","phase":"NA","title":"Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well","status":"NOT_YET_RECRUITING","sponsor":"Amrou Sarraj","startDate":"2026-01-01","conditions":"Acute Ischemic Stroke","enrollment":408},{"nctId":"NCT05997693","phase":"PHASE3","title":"One-Month DAPT in CABG Patients","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2024-08-15","conditions":"Chronic Coronary Disease","enrollment":700},{"nctId":"NCT06321757","phase":"","title":"PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients","status":"RECRUITING","sponsor":"Fundación EPIC","startDate":"2024-02-26","conditions":"Coronary Artery Disease","enrollment":501},{"nctId":"NCT06548971","phase":"PHASE3","title":"Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2024-11-07","conditions":"Acute Ischemic Stroke, Cerebral Infarction","enrollment":1184},{"nctId":"NCT04783701","phase":"","title":"Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)","status":"RECRUITING","sponsor":"University Hospital, Linkoeping","startDate":"2021-05-17","conditions":"Acute Coronary Syndrome, Coronary Bypass Stenosis","enrollment":360},{"nctId":"NCT05257824","phase":"PHASE4","title":"Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2022-06-23","conditions":"Aneurysm Cerebral, Endovascular Procedures","enrollment":528},{"nctId":"NCT02770066","phase":"","title":"A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2015-01-01","conditions":"Renal Artery Obstruction, Hypertension, Renovascular, Cardiovascular Diseases","enrollment":160},{"nctId":"NCT07290699","phase":"PHASE4","title":"Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Nanchang University","startDate":"2026-01-01","conditions":"STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)","enrollment":2442},{"nctId":"NCT07198529","phase":"NA","title":"OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina","status":"RECRUITING","sponsor":"Korea University Guro Hospital","startDate":"2025-09-30","conditions":"Stable Angina, Coronary Artery Disease","enrollment":130},{"nctId":"NCT06472336","phase":"NA","title":"IntraCranial Atherosclerosis Related Large-vessel Occlusion Treated With Urgent Stenting (ICARUS)","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-03-31","conditions":"Stroke, Stroke, Acute Ischemic, Intracranial Atherosclerosis","enrollment":498}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":17884,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ticagrelor, aspirin","The brand name of clopidogrel is Plavix.","The brand name of cilostazol is Pletaal."],"phase":"marketed","status":"active","brandName":"Antiplatelet therapy","genericName":"Antiplatelet therapy","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antiplatelet therapy inhibits platelet aggregation to prevent blood clot formation and reduce thrombotic events. Used for Acute coronary syndrome, Secondary prevention of myocardial infarction, Stroke prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}